Mesa Laboratories Inc /co (MLAB): John James Sullivan , President and CEO of Mesa Laboratories Inc /co sold 4,000 shares on Jun 22, 2016. The Insider selling transaction was reported by the company on Jun 23, 2016 to the Securities and Exchange Commission. The shares were sold at $121.63 per share for a total value of $486,520.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 8, 2016, Glenn E Adriance (CSMO) sold 3,000 shares at $111.74 per share price.On Mar 9, 2016, H Stuart Campbell (director) sold 280 shares at $90.00 per share price.Also, On Nov 9, 2015, John James Sullivan (President and CEO) sold 2,400 shares at $112.99 per share price.On Sep 17, 2015, Robert V Dwyer (director) sold 2,000 shares at $113.00 per share price.
Shares of Mesa Laboratories (MLAB) ended Tuesday, Jun 21, 2016 session in red amid volatile trading. The shares closed down -0.62 points or -0.51% at $122.11 with 9,164 shares getting traded. Post opening the session at $123.01, the shares hit an intraday low of $121.56 and an intraday high of $123.98 and the price vacillated in this range throughout the day. The company has a market cap of $444 M and the number of outstanding shares has been calculated to be 36,38,723 shares. The 52-week high of Mesa Laboratories is $131.88 and the 52-week low is $77.
Company has been under the radar of several Street Analysts.Mesa Laboratories is Downgraded by Sidoti to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Jun 10, 2016.
Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.